1. Introduction {#sec0005}
===============

The elementary importance of mitochondrial Ca^2+^ uptake for the regulation of the organelle\'s physiological functions [@bib0005] and dysfunctions [@bib0010; @bib0015] is convincingly reported. Mitochondria accumulate Ca^2+^ from high Ca^2+^ microdomains that are generated particularly in the vicinity of Ca^2+^ release channels of the endoplasmic reticulum (ER) [@bib0020; @bib0025; @bib0030] and Ca^2+^ entry channels of the plasma membrane (PM) upon acute cell stimulation [@bib0035; @bib0040]. Hence, mitochondria sequester Ca^2+^ from moderate submicromolar cytosolic Ca^2+^ elevations in intact cells by an obvious shift in their Ca^2+^ sensitivity of the Ca^2+^ sequestration pathway [@bib0045; @bib0050; @bib0055]. This versatile competency of mitochondria to decode various cellular Ca^2+^ signals is accomplished by Ca^2+^ channels and Ca^2+^ exchangers at the inner mitochondrial membrane (IMM) that govern different modes of mitochondrial Ca^2+^ uptake [@bib0040]. In addition the transfer of Ca^2+^ across the IMM appears to be modulated by posttranslational modifications, such as phosphorylation [@bib0060; @bib0065], small diffusible messengers such as nucleotides [@bib0070] or polyamines [@bib0075], the proton concentration within the matrix of mitochondria [@bib0080] and Ca^2+^ itself [@bib0085; @bib0090], which all are thought to affect the activity of mitochondrial Ca^2+^ channels in intact cells. Such a sophisticated regulation of mitochondrial Ca^2+^ channels by multiple processes is thought to be essential in order to balance mitochondrial Ca^2+^ accumulation, which not only stimulates respiration and ATP synthesis [@bib0095] but also can evoke cell death [@bib0100]. However, the exact molecular mechanisms as well as their putative interdependencies, which actually control mitochondrial Ca^2+^ signaling in intact cells remain unclear over a large extent.

Mitochondrial Ca^2+^ channels are functionally well characterized and convincing electrophysiological recordings of single Ca^2+^ channel activities on mitoplasts (isolated swollen mitochondria lacking the outer mitochondrial membrane) have been presented [@bib0105; @bib0110]. Notably, such studies not only proved unambiguously the existence of a functional mitochondrial Ca^2+^ channel at the IMM but also unveiled the presence of distinct mitochondrial Ca^2+^ channels with different properties [@bib0110], challenging the concept of a unique mitochondrial Ca^2+^ uniporter (MCU) [@bib0040]. In contrast to these remarkable achievements regarding the functional characterization of mitochondrial Ca^2+^ channels, mitochondrial Ca^2+^ channel proteins have not been conclusively identified so far. Nevertheless, very recently an EF-hand containing protein referred to as mitochondrial calcium uptake 1 (MICU1) has been identified to essentially contribute to the mitochondrial Ca^2+^ uptake machinery [@bib0115]. Although MICU1 has been shown to be required for high capacity mitochondrial Ca^2+^ uptake, based on the predicted structural features of MICU1 this protein seems to rather function as a regulator of (a) mitochondrial Ca^2+^ channel(s) than to act itself as a Ca^2+^ channel of the IMM [@bib0115].

In recent reports we [@bib0120] and others [@bib0125] described the fundamental importance of UCP2/3 for mitochondrial Ca^2+^ accumulation in intact cells [@bib0130], indicating that these proteins either exhibit conductive subunits of a mitochondrial Ca^2+^-selective ion channel or function as essential modulators of one of the major mitochondrial Ca^2+^ uptake routes. However, these findings were challenged [@bib0135] and it became apparent that the disclosure of a UCP2/3-dependent mitochondrial Ca^2+^ uniport critically depends on the experimental procedures and models chosen [@bib0140]. However, we have recently demonstrated that constitutively expressed UCP2/3 preferentially contribute to mitochondrial Ca^2+^ uptake from the intraorganelle gap between the mitochondria and the ER and account for mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^, while these proteins did not contribute to mitochondrial Ca^2+^ uptake of entering Ca^2+^. However, once UCP2/3 have been overexpressed, mitochondrial Ca^2+^ uptake was significantly enhanced independently from the source and mode of supplied Ca^2+^ (i.e. intracellularly released Ca^2+^ vs. Ca^2+^ entering the cell via the so called store-operated Ca^2+^ entry, SOCE). Thus, the contribution of UCP2/3 to mitochondrial Ca^2+^ sequestration appears to be determined by the source of supplied Ca^2+^ as well as their expression levels.

In the present work we used site-directed mutagenesis of UCP3 (and UCP2) to elucidate the structural determinants of such a distinct contribution of the novel UCPs to mitochondrial Ca^2+^ uptake depending on the source, mode and hence strength of supplied Ca^2+^.

2. Materials and methods {#sec0010}
========================

2.1. Materials {#sec0015}
--------------

Cell culture chemicals were purchased at Invitrogen (Vienna, Austria) and fetal calf serum and media supplements were from PAA laboratories (Pasching, Austria). Dulbecco\'s modified eagle\'s medium (DMEM), 2,5-di-tert-butylhydroquinone (BHQ), histamine, oligomycin, and digitonin were obtained from Sigma--Aldrich (Vienna, Austria). 7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H) (CGP 37157), and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) were from Tocris Bioscience (Bristol, UK). Ru360 was ordered from EMD Chemicals Inc. (Gibbstown, NJ, USA) Fura-2/AM and 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) was obtained from Molecular Probes Europe (Leiden, Netherlands). All other chemicals were from Roth (Karlsruhe, Germany).

2.2. Cell culture and transfection {#sec0020}
----------------------------------

The human umbilical vein endothelial cell line EA.hy926 [@bib0145] (passage 45--85) stably expressing RPmt was used in this study. Cells were grown in DMEM containing 10% FCS, 1% HAT (5 mM hypoxanthin, 20 μM aminopterin, 0.8 mM thymidine), 50 units/ml penicillin, 50 μg/ml streptomycin, and were maintained at 37 °C in 5% CO~2~ atmosphere. For experiments, cells were plated on 30 mm glass cover slips 2--4 days before use. After reaching 70--80% of confluence, cells were transiently transfected with the different plasmids using the Transfast^®^ reagent according to the protocol supplied by the manufacturer. For measurements of mitochondrial Ca^2+^ concentration, the protein/mutant of interest was co-transfected with a nuclear-targeted GFP (NLS-GFP) [@bib0150] in a ratio of 3:1 to identify overexpressing cells. In analogy the protein/mutant of interest was co-transfected with mtDsRed [@bib0155] and/or D1~ER~ [@bib0160] for structural analysis of the organelles. All constructs were confirmed by restriction digestion and sequencing. Experiments were performed between 42 and 48 h after transfection.

2.3. Plasmid construction for UCP overexpression {#sec0025}
------------------------------------------------

Full length human UCPs, UCP1 (GenBank accession no. [NM_021833.4](ncbi-n:NM_021833.4)), UCP2 (GenBank accession no. [NM_003355.2](ncbi-n:NM_003355.2)) and UCP3 (GenBank accession no. [NM_003356.3](ncbi-n:NM_003356.3)) were subcloned from previously described constructs [@bib0120] into the CMV-controlled multiple cloning site of the mammalian expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA) by restriction digests using NotI-XhoI (UCP1) or KpnI-XhoI (UCP2 and UCP3) respectively as recently described [@bib0165].

2.4. Generation of UCP chimeras {#sec0030}
-------------------------------

Applying a three-step PCR approach, the UCP2/3 specific intermembrane loop 2 (IML2) of UCP2 and UCP3 was replaced by that of UCP1 to provide the UCP2^UCP1^, UCP3^UCP1^ chimeras. Moreover, the IML2 of UCP1 was replaced by that of UCP2 (UCP1^UCP2^). All chimeras were cloned into pcDNA3.1 using either KpnI-XhoI (UCP2^UCP1^ and UCP3^UCP1^) or EcoRI-XhoI (UCP1^UCP2^).

2.5. Mutagenesis of UCP3 {#sec0035}
------------------------

For UCP3 point mutations suitable primers (5′-CTATGGACGCCTACGGAACCATCGCCAGG-3′ and 5′-CCTGGCGATGGTTCCGTAGGCGTCCATAG-3′ for UCP3^R167G^ or 5′-CAGAACCATCGCCGGGGGGGAAGGAGTCAGG-3′ and 5′-CCTGACTCCTTCCCCCCCGGCGATGGTTCTG-3′ for UCP3^RE171/172GG^, respectively) exchanged the corresponding codons from AGA to GGA (UCP3^R167G^) or from AGG GAG to GGG GGG (UCP3^RE171/172GG^), respectively. Mutants were constructed by using the QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA).

2.6. Solutions and cell permeabilization {#sec0040}
----------------------------------------

Cell loading with Fura-2/AM and at rest prior to experiments, cells were kept in a Hepes-buffered solution containing (in mM): 135 NaCl, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, 10 Hepes acid, 2.6 NaHCO~3~, 0.44 KH~2~PO~4~, 10 glucose, 0.1% vitamins and 0.2% essential amino acids, 1% penicillin/streptomycin, pH adjusted to 7.4 with NaOH. For experiments in the nominal absence of extracellular Ca^2+^ the Ca^2+^ free buffer composed of (in mM): 138 NaCl, 5 KCl, 1 MgCl~2~, 1 EGTA, 10 glucose and 10 Hepes acid, pH adjusted to 7.4 with NaOH. Prior switching to EGTA-containing solution, and for experiments in the presence of extracellular Ca^2+^, cells were perfused with a solution containing (in mM): 138 NaCl, 5 KCl, 1 MgCl~2~, 2 CaCl~2~, 10 [d]{.smallcaps}-glucose and 10 Hepes acid, pH adjusted to 7.4 with NaOH. If not otherwise indicated, this solution was normally used in the Ca^2+^ readdition experiments with intact cells. For mild cell permeabilization cells were perfused with 3 μM digitonin for 3 min in high KCl-buffer composed of (in mM): 110 KCl, 0.5 KH~2~PO~4~, 1 MgCl~2~, 20 Hepes, 0.03 EGTA, 5 succinate, 10 [d]{.smallcaps}-glucose, pH adjusted to 7.4 with KOH. To trigger mitochondrial Ca^2+^ uptake cells were partially permeabilized and the actual intracellular Ca^2+^ concentration (\[Ca^2+^\]~a~) was set to 174 ± 18 nM (*n* = 17) (referred as "low Ca^2+^"), 319 ± 21 nM (*n* = 20) (referred as "middle Ca^2+^") and 921 ± 119 nM (*n* = 17) (referred as "high Ca^2+^") as calculated using Fura-2 and the following equation: \[Ca^2+^\]~a~ = 350 nM·(*F*^Ca^ − *F*^min^)/(*F*^max^ − *F*^Ca^).

2.7. Ca^2+^ measurements {#sec0045}
------------------------

Free *mitochondrial Ca*^*2+*^ *concentration* was measured with mitochondria-targeted ratiometric-pericam [@bib0170] using a fluorescence microscope (Zeiss Axiovert 100/AxioObserver, Zeiss, Vienna, Austria) as previously described [@bib0175; @bib0180]. Due to the sensor sensitivity to changes in pH at 480 nm excitation data presented are normalized to 1 − (*F*~430~/*F*~0~) as described previously [@bib0120]. *Cytosolic free Ca*^*2+*^ was recorded with Fura-2/am [@bib0185] using fluorescence microscope as previously described [@bib0190]. Cytosolic free Ca^2+^ is expressed as ratio of the fluorescence at 340 and 380 nm excitation (*F*~340~/*F*~380~). The *free Ca*^*2+*^ *concentration within the ER* lumen was monitored using D1~ER~ [@bib0160] as previously described [@bib0175; @bib0195]. D1~ER~ was excited at 440 ± 21 nm (440AF21, Omega Optical) and emission was collected simultaneously at 535 and 480 nm with one given camera using an optical beam splitter (535 and 480 nm, Dual-View MicroImagerTM, Optical Insights, Visitron Systems).

2.8. Array confocal laser scanning microscopy {#sec0050}
---------------------------------------------

High-resolution imaging of cells expressing mtDsRed and/or D1~ER~ was performed using a Nipkow-disk-based array confocal laser scanning microscope (ACLSM) as described previously [@bib0120; @bib0180]. The ACLSM consisted of a Zeiss Axiovert 200M (Zeiss Microsystems, Jena, Germany) with a 100× objective (α Plan-Fluar 100×/1.45 oil objective, Zeiss Microsystems, Jena, Germany), equipped with VoxCell Scan^®^ (VisiTech, Sunderland, UK), and an air cooled argon ion laser system (series 543, CVI Melles Griot, CA, USA). The laser line 488 nm was used to excite fluo4 and D1~ER~, whereas alternatively wavelength 514 nm was used to excite mtDsRed. Emitted light was collected at 535 nm (535AF26; Omega Optical, Brattleboro, VT, USA) for fluo4 and D1~ER~ or 570 nm (Omega optical) for mtDsRed using a high resolution CCD camera (Photometrics CoolSNAP~fx~-HQ, Roper Scientific, Tucson, AZ, USA). Acquisition and analysis were performed with Metamorph 6.2r6 (Universal Imaging, Visitron Systems, Puchheim, Germany). The deconvolution of *z*-scans with the iterative quick maximum likelihood estimation algorithm (QMLE) was performed with Huygens 2.4.1p3, software (Hilversum, Netherlands). 3D-rendering of ER and mitochondria were done with the Imaris 3.3 software (Bitplane AG, Zürich, Switzerland) [@bib0120; @bib0195].

2.9. Statistics {#sec0055}
---------------

Analysis of variance (ANOVA) and Dunnett\'s Multiple Comparison Test were used for the analysis. *P* \< 0.05 was determined to be significant.

3. Results {#sec0060}
==========

3.1. Chimeras of UCP2/3 containing the intermembrane loop 2 of UCP1 selectively achieve uptake of entering but not that of intracellularly mobilized Ca^2+^ {#sec0065}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

In our recent work the UCP2/3-specific intermembrane loop 2 (IML2), in which the highest heterogeneity with UCP1 exists ([Fig. 1](#fig0005){ref-type="fig"}A), was found to be critical for the contribution of UCP2/3 to mitochondrial Ca^2+^ uptake [@bib0120]. This assumption was built on mutations in IML2 with a replacement of amino acids 160--169 (UCP2) and 163--172 (UCP3), respectively, with equivalent [l]{.smallcaps}-glycines. Interestingly, UCP1, which has been proven to establish a proton leak in intact cells under certain conditions [@bib0200; @bib0205], was found to be inactive in terms of mitochondrial Ca^2+^ uptake [@bib0120]. Because of the striking heterogeneity of UCP2/3 vs. UCP1 in the IML2, we first investigated whether the substitution of IML2 of UCP2 and UCP3 by that of UCP1 ([Fig. 1](#fig0005){ref-type="fig"}B) affects the Ca^2+^ function of the two novel uncoupling proteins. Both chimeras, i.e. UCP2^UCP1^ and UCP3^UCP1^, had no effect on mitochondrial sequestration of intracellularly released Ca^2+^ while these UCP mutants mimicked the effects of the wild-type isomers regarding a strong enhancement of mitochondrial uptake of entering Ca^2+^ ([Fig. 1](#fig0005){ref-type="fig"}C). These data differed from the effects of an overexpression of the wild-type proteins that yielded significantly enhanced mitochondrial Ca^2+^ uptake from intracellularly released and entering Ca^2+^ ([Fig. 1](#fig0005){ref-type="fig"}D), thus, pointing to the respective IML2 to be essential for the contribution of UCP2/3 to mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^. Notably, like their wild-type isoforms [@bib0120], UCP2^UCP1^ and UCP3^UCP1^ had no effect on cytosolic Ca^2+^ signaling (data not shown).

Since the substitution of the entire IML2 by [l]{.smallcaps}-glycine in UCP2/3 was found to be inactive in terms of mitochondrial Ca^2+^ uptake independently from its source [@bib0120], we speculated that the IML2 of the UCP1 contains a distinct site that is suitable to accomplish the contribution to mitochondrial uptake of entering Ca^2+^ but not of intracellularly released Ca^2+^ if it replaces the IML2 of UCP2/3.

In contrast, expression of the UCP1^UCP2^ chimera in which the IML2 in UCP1 was replaced by that of UCP2 failed to reveal any changes in mitochondrial Ca^2+^ uptake, indicating that the exchange of just the IML2 from UCP2 to UCP1 is insufficient to establish some Ca^2+^ transport function ([Fig. 1](#fig0005){ref-type="fig"}E).

3.2. Site directed mutagenesis reveals distinct positions in UCP3 that diversely mediate mitochondrial uptake of Ca^2+^ from different sources {#sec0070}
----------------------------------------------------------------------------------------------------------------------------------------------

Alignment of the respective IML2 sequences ([Fig. 1](#fig0005){ref-type="fig"}A) revealed that UCP1, UCP2 and UCP3 strikingly share a basic amino acid residue ([l]{.smallcaps}-arginine or [l]{.smallcaps}-lysine) in positions 162, 164 and 167, respectively. Hence, only UCP2 and UCP3 contain a second basic residue (i.e. [l]{.smallcaps}-arginine) at positions 168 and 171, respectively, while UCP1 has an [l]{.smallcaps}-threonine at the respective position (166). In order to investigate the importance of the two basic domains in the IML2 for the discriminating function of UCPs regarding the two different sources (i.e. intracellular release and entry), the [l]{.smallcaps}-arginine residue in position(s) 167 (UCP3^R167G^) or 171/172 (UCP3^RE171/172GG^) in the IML2 of UCP3 was substituted by [l]{.smallcaps}-glycine(s) ([Fig. 2](#fig0010){ref-type="fig"}A).

As in our previous studies the mutation in IML2 of UCP3 with a replacement of amino acids 163--172 by [l]{.smallcaps}-glycines did not affect the mitochondrial targeting [@bib0120] it can be assumed safely that the mutants UCP3^R167G^ and UCP3^RE171/172GG^ are also well targeted towards the IMM. In line with these findings, UCP3^R167G^ and UCP3^RE171/172GG^ mutants did neither affect basal ER Ca^2+^ content ([Fig. 2](#fig0010){ref-type="fig"}B), agonist-triggered ER Ca^2+^ depletion, subsequent ER Ca^2+^ refilling ([Fig. 2](#fig0010){ref-type="fig"}C), nor the architecture of the ER ([Fig. 2](#fig0010){ref-type="fig"}D). Both UCP3 mutants did not affect the overall structure and shape of mitochondria ([Fig. 2](#fig0010){ref-type="fig"}E and F) or the average surface area, volume and number of mitochondria per cell ([Fig. 2](#fig0010){ref-type="fig"}G). Moreover, a more detailed analysis on potential effects of these mutants on the architectural organization of mitochondria revealed that the expression of the UCP3^R167G^ or UCP3^RE171/172GG^ mutant had no effect on the cellular distribution of these organelles that was verified by analyzing the relative position of mitochondria to the cell center ([Fig. 2](#fig0010){ref-type="fig"}H and I).

Like their wild-type isoforms and the UCP2^UCP1^/UCP3^UCP1^ chimeras, the UCP3^R167G^ and UCP3^RE171/172GG^ mutants had no effect on cytosolic Ca^2+^ signals that were triggered by ER Ca^2+^ mobilization and store operated Ca^2+^ entry ([Fig. 3](#fig0015){ref-type="fig"}A and B, respectively). However, in agreement with our experiments with the UCP2^UCP1^/UCP3^UCP1^ chimeras described above, the UCP3^RE171/172GG^ mutant had no effect on mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^ but mimicked wild-type UCP3 in the strong elevation of mitochondrial sequestration of entering Ca^2+^ ([Fig. 3](#fig0015){ref-type="fig"}C). These data demonstrate a crucial importance of a basic residue in position 171 of the UCP3 exclusively for the protein\'s contribution to mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^. Strikingly, the UCP3^R167G^ mutant mimicked its wild-type isoform in regard to its elevating effect on mitochondrial Ca^2+^ accumulation of intracellularly released Ca^2+^ but failed to affect mitochondrial Ca^2+^ uptake of entering Ca^2+^ ([Fig. 3](#fig0015){ref-type="fig"}D), pointing to a crucial importance of the basic residue in position 167 of UCP3 exclusively for mitochondrial Ca^2+^ uptake of entering Ca^2+^.

Like that of the wild-type UCP3, mitochondrial Ca^2+^ uptake by both UCP3 mutants was sensitive to mitochondrial depolarization, while under these conditions their principal differences in responsiveness remained. In particular, despite the overall mitochondrial Ca^2+^ uptake was largely reduced under depolarizing conditions, the UCP3^R167G^ mutant still behaved like an overexpressed wild-type UCP3 and yielded almost 3-fold elevation of mitochondrial Ca^2+^ accumulation, while the UCP3^RE171/172GG^ mutant had no effect on mitochondrial uptake of intracellularly released Ca^2+^ ([Fig. 4](#fig0020){ref-type="fig"}A and B). In contrast, neither the wild-type UCP3 nor its mutants yielded effects on mitochondrial sequestration of entering Ca^2+^ under conditions of mitochondrial depolarization ([Fig. 4](#fig0020){ref-type="fig"}C and D), possibly due to the strongly reduced Ca^2+^ entry under these conditions (data not shown).

3.3. The kinetics of the delivery of Ca^2+^ to mitochondria and the subsequent Ca^2+^ sequestration into the organelle depend on the mode and source of Ca^2+^ mobilization {#sec0075}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Accordingly, two distinct residues were described herein that are essential for the contribution of UCP3 to mitochondrial sequestration of Ca^2+^ provided from distinct sources, the ER and the extracellular area. These findings are in line with the current concept of specific coupling between the ER and the mitochondria [@bib0020; @bib0210; @bib0215; @bib0220; @bib0225] and lead us to hypothesize that limited, optimized Ca^2+^ transfer sites between the ER and the mitochondria exist [@bib0165]. Two recent studies convincingly demonstrate that Ca^2+^ hot spots on the surface of mitochondria are established by intracellularly released Ca^2+^ but not store-operated Ca^2+^ entry [@bib0230; @bib0235]. In agreement with this work, the promptitude of mitochondrial sequestration of intracellularly released Ca^2+^ (i.e. the time to reach maximum rate, $T_{R_{\text{max}}}$) appears to be very similar despite independently from the actual amount of Ca^2+^ release ([Fig. 5](#fig0025){ref-type="fig"}A), thus, indicating a rather direct functional coupling between the ER and the mitochondria. In contrast, the promptitude ($T_{R_{\text{max}}}$) of mitochondrial Ca^2+^ uptake of entering Ca^2+^ critically depended on the actually strength of Ca^2+^ entry ([Fig. 5](#fig0025){ref-type="fig"}A and B), thus, indicating that the functional plasma-membrane-to-mitochondria Ca^2+^ coupling critically depends on the strengths and dynamics of Ca^2+^ entry. Moreover, the analysis of mitochondrial contact sites with the ER and the plasma membrane revealed a large proportion of mitochondria to be in close proximity with the ER while the proximity of the mitochondria with the plasma membrane was very limited in the cell type used for this study ([Fig. 5](#fig0025){ref-type="fig"}B).

3.4. Mutations in the IML2 of UCP3 exhibit different Ca^2+^ sensitivities that scope the different demands of mitochondrial uptake of high and low Ca^2+^ signals {#sec0080}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

Altogether, there is evidence that the actual Ca^2+^ concentration at the mitochondrial surface differs from the source of Ca^2+^ (i.e. intracellular Ca^2+^ release vs. Ca^2+^ entry) mobilization. Consequently, one might speculate that the two UCP3 mutations that exclusively mimicked the wild-type UCP3 in sequestration of either intracellularly released (UCP3^R167G^) or entering Ca^2+^ (UCP3^RE171/172GG^) might exhibit different Ca^2+^ sensitivities. In order to test possible differences in the Ca^2+^ sensitivity of UCP3^R167G^ and UCP3^RE171/172GG^ compared with that of the wild-type UCP3, experiments on mitochondrial Ca^2+^ uptake in digitonin-permeabilized cells that (over)expressed the respective UCP3 isoforms were performed. The Ca^2+^ sensitivities of the UCP3 isoforms were tested by the addition of a low, middle and high Ca^2+^ concentration to permeabilized cells. Thereby the actual Ca^2+^ concentrations that were reached within digitonin-permeabilized cells were 174 ± 18 nM at low Ca^2+^ concentration, 319 ± 21 nM at middle Ca^2+^ concentration and 921 ± 119 nM at high Ca^2+^ concentration. Overexpression of wild-type UCP3 yielded similar increase in mitochondrial Ca^2+^ sequestration upon all Ca^2+^ concentrations applied ([Fig. 6](#fig0030){ref-type="fig"}A and B). The expression of the UCP3^RE171/172GG^ mutant mimicked the effect of an overexpression of wild-type UCP3 only upon the addition of low Ca^2+^ while its effect was reduced upon the addition of middle and completely lost upon the addition of high Ca^2+^ ([Fig. 6](#fig0030){ref-type="fig"}A and B). In contrast, expression of the UCP3^R167G^ mutant had no effect on the mitochondrial uptake upon low concentration of Ca^2+^, while it was more effective than the wild-type UCP3 upon the addition of middle and high Ca^2+^ ([Fig. 6](#fig0030){ref-type="fig"}A and B).

Experiments under these conditions with the ruthenium amine derivate Ru360, a specific inhibitor of mitochondrial Ca^2+^ uniport [@bib0240], revealed similar sensitivities of the UCP3 mutants to Ru360 on the respective Ca^2+^ signals than that found for the wild-type UCP3 ([Fig. 6](#fig0030){ref-type="fig"}C and D).

Overall these findings point to distinct Ca^2+^ sensitivities that are determined by two probably interacting sites within the IML2 of UCP3. Moreover these results reveal a sophisticated molecular switch that is able to adjust the UCP3-dependent mitochondrial Ca^2+^ uniport to versatile Ca^2+^ signals ([Fig. 7](#fig0035){ref-type="fig"}).

4. Discussion {#sec0085}
=============

While there is increasing evidence that support the concept of UCP2/3 as being part of the/a mitochondrial Ca^2+^ uniporter [@bib0120; @bib0125; @bib0130; @bib0165; @bib0245], the putative involvement of UCP2 and UCP3 to mitochondrial Ca^2+^ uptake is still a matter of controversy [@bib0005; @bib0250; @bib0255; @bib0260]. Moreover, the co-existence of more than one function- and molecular-distinct mitochondrial Ca^2+^ uptake route has been recently demonstrated [@bib0110; @bib0165; @bib0265; @bib0270], thus, challenging the concept of one protein/phenomenon to be responsible for mitochondrial Ca^2+^ sequestration. Accordingly, the aim of this work was to provide the first mechanistic insights into the UCP2/3-dependent mitochondrial Ca^2+^ uptake machinery in order to proceed with the dissection of the different mitochondrial Ca^2+^ sequestration mechanisms. Overall our present data suggest that UCP3 works as a complex molecular switch with two levels of a Ca^2+^ sensitivity for its contribution to mitochondrial Ca^2+^ uptake ([Fig. 7](#fig0035){ref-type="fig"}) of which the essential structural determinants are embedded in the IML2.

In our previous work, UCP1 was found to be inactive in regard to mitochondrial Ca^2+^ uptake [@bib0120]. Moreover, a supplementation of the characteristic IML2 sequence in UCP2 and UCP3 by [l]{.smallcaps}-glycines (UCP2/3^6G^) prevented any Ca^2+^ function of these proteins, thus indicating that the IML2 is crucial for the contribution of UCP2/3 to mitochondrial Ca^2+^ uptake. Our present findings that the chimera in which the IML2 of UCP1 was supplemented by that of UCP2 (UCP1^UCP2^) could not establish any mitochondrial Ca^2+^ uptake ([Table 1](#tbl0005){ref-type="table"}) indicate that for establishing the contribution of UCPs to mitochondrial Ca^2+^ uptake other domains of the UCP2/3 proteins besides the IML2 are essential.

Nevertheless, the distinct role of the IML2 for the Ca^2+^ function of UCP2/3 was further demonstrated by using the converse chimeras in which the IML2 of UCP2 and UCP3 was replaced by that of UCP1 (UCP2^UCP1^ and UCP3^UCP1^). In particular, our findings that both chimeras had no effect in terms of mitochondrial sequestration of intracellularly released Ca^2+^ while they mimicked the effect of wild-type UCP2/3 on mitochondrial uptake of entering Ca^2+^ significantly differ from the previous results with UCP2/3^6G^ ([Table 1](#tbl0005){ref-type="table"}). These differences indicate that the sequence of the IML2 of UCP1 in either UCP2 (UCP2^UCP1^) or UCP3 (UCP3^UCP1^) exclusively supports the uptake of entering Ca^2+^. Since none of the chimeras affected the respective cytosolic Ca^2+^ signaling, these data point to specific changes in the activity of mitochondrial Ca^2+^ uptake upon IML2 variations rather than changes in the Ca^2+^ supply to the surface of the mitochondria.

Using sequence-based annotation analysis, the comparison of the IML2 of UCP1 vs. that of UCP2/3 revealed that all proteins share a basic residue at the N-terminal side of the IML2. This is [l]{.smallcaps}-arginine in position 162 of UCP1 and 167 of UCP3 as well as [l]{.smallcaps}-lysine in position 164 of UCP2. In view of our previous findings with the inactive UCP2/3^6G^ mutants [@bib0120] and the properties of UCP2^UCP1^ and UCP3^UCP1^ to exclusively sequester entering but not intracellularly released Ca^2+^, we speculated that the N-terminal basic amino acid residue in the IML2 at position 164 and 167 of the IML2 of UCP2 and UCP3, is essential for the contribution of these proteins to the uptake of entering Ca^2+^. This hypothesis was further proven by our experiments with the UCP3 mutant, in which the [l]{.smallcaps}-arginine at position 167 was supplemented by an [l]{.smallcaps}-glycine (UCP3^R167G^). Strikingly, expression of UCP3^R167G^ yielded elevated mitochondrial uptake of intracellularly released Ca^2+^ while this mutant was obviously inactive to contribute to the mitochondrial Ca^2+^ uptake of entering Ca^2+^. Overall these data indicate that the N-terminal basic amino acid residue of the IML2 in UCP2/3 is crucial for the contribution of these proteins to mitochondrial uptake of entering Ca^2+^.

Since neither the UCP2/3^6G^ nor the UCP2^UCP1^ and UCP3^UCP1^ exhibited any activity in regard to mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^, a crucial role of amino acid residues at the C-terminal site of IML2 for this particular function of UCP2 and UCP3 was hypothesized. In line with this assumption, the C-terminal region of IML2 in UCP1 significantly differs from that of UCP2/3. In particular, the protonated A-R-E-E sequence of positions 168--170 of UCP2 and 171--173 of UCP3, respectively, significantly differs from the polar A-T-T-E domain of UCP1. Accordingly, we speculated this sequence to be crucial for the contribution of UCP2/3 to mitochondrial Ca^2+^ uptake of intracellularly released Ca^2+^. Our findings that the UCP3 mutant in which the [l]{.smallcaps}-arginine and [l]{.smallcaps}-glutamate in positions 171 and 172, respectively, were substituted with [l]{.smallcaps}-glycines (UCP3^RE171/172GG^) exclusively exhibited elevated mitochondrial uptake of entering but not intracellularly released Ca^2+^ strongly support our conclusion that the C-terminal protonated residue of the IML2 in UCP2/3 is crucial for the contribution of these proteins to mitochondrial uptake of intracellularly released Ca^2+^.

Importantly, our findings that neither UCP3^RE171/172GG^ nor UCP3^R167G^ affected histamine-induced cytosolic Ca^2+^ signaling or ER Ca^2+^ depletion, ER architecture, or mitochondrial structure and cellular distribution indicate that different properties of the two UCP3 mutants for mitochondrial Ca^2+^ accumulation upon stimulation are due to their effect on the competence of mitochondria to sequester either intracellularly released or entering Ca^2+^. This assumption is further supported by the sensitivity of both mutants to mitochondrial depolarization and Ru360 that was not distinguishable from that of wild-type UCP3. Accordingly, these data describe two specific motifs in the IML2 of UCP2 and UCP3 to be essential for the Ca^2+^ function of these proteins ([Table 1](#tbl0005){ref-type="table"}). Interestingly, these particular sequences in the IML2 of UCP2 and UCP3 are specific for these proteins and are not shared by any other member of the UCP family and, thus, do not belong to the so-called UCP signatures in the first, second and fourth α-helix [@bib0275; @bib0280]. The lack of such specific sequences might explain the negative findings in a genome-wide *Drosophila* RNA interference screen [@bib0265] as the Drosophila UCPs only share app. 30% homology with UCP2 and UCP3 and do not contain the particular motifs in their predicted IML2 ([Table 2](#tbl0010){ref-type="table"}).

While these findings highlight the essential existence of two sites in the IML2 for the contribution of UCP2/3 to mitochondrial uptake from Ca^2+^ from the two major sources (i.e. intracellular Ca^2+^ release and store-operated Ca^2+^ entry) in non-excitable cells, the actual molecular cause of the differences in the activity of the two UCP3 mutants in terms of the source of supplied Ca^2+^ remains illusive. However, our present finding on the different Ca^2+^ sensitivities of the UCP3 mutants and the comparison with the wild-type UCP3, provide important information that can explain the observed differences in the contribution of UCP3 mutants to mitochondrial uptake of Ca^2+^ supplied varyingly strong from different sources.

A specific coupling between the ER and the mitochondria [@bib0020; @bib0210; @bib0215; @bib0220; @bib0225; @bib0285] and the existence of Ca^2+^ hot spots on the surface of mitochondria by intracellularly released but not entering Ca^2+^ have been demonstrated [@bib0230]. Our data on the different kinetics of mitochondrial sequestration of Ca^2+^ either supplied by intracellular Ca^2+^ release or store-operated Ca^2+^ entry are in agreement with these reports and further point to differences in the kinetics and local concentration of supplied Ca^2+^ by intracellular stores (i.e. fast kinetics and high Ca^2+^ concentration) vs. the store-operated Ca^2+^ entry pathway (i.e. slow kinetics with moderate Ca^2+^ elevation) at the mitochondrial surface. Such diversity in the superficial Ca^2+^ concentration at the mitochondrial surface requires either multiple carriers and/or different uptake modes in order to achieve the decoding of versatile cellular Ca^2+^ signals by mitochondria.

Though multiple carriers for mitochondrial Ca^2+^ uptake have been described [@bib0110; @bib0165; @bib0265], reviewed in [@bib0040], there is strong evidence that the given mitochondrial Ca^2+^ uniport phenomenon might work in different modes depending on distinct Ca^2+^ sensitivities [@bib0045; @bib0050; @bib0055]. In this study the wild-type UCP3 was found to cover a large range of Ca^2+^ signals to be sequestered into the mitochondria, thus indicating that one given protein is capable to contribute to mitochondrial Ca^2+^ uptake at low and high Ca^2+^ concentrations. Moreover, two Ca^2+^ sensitivities of the UCP3 became obvious when testing the UCP3 mutants, thus supporting the concept of various modes of mitochondrial Ca^2+^ uptake described by others [@bib0050; @bib0055; @bib0290]. In particular, the experiments with digitonin-permeabilized cells revealed that the UCP3^R167G^ mutant exhibits almost normal function at high Ca^2+^ concentration but lacks Ca^2+^ uptake activity under low Ca^2+^ conditions. These characteristics perfectly match the results in intact cells in which UCP3^R167G^ mimicked the wild-type protein in regard to mitochondrial uptake of intracellularly released Ca^2+^, while it appeared to be inactive to sequester entering Ca^2+^. On the other hand, the UCP3^RE171/172GG^ mutant, which mimicked the wild-type UCP3 exclusively for mitochondrial uptake of entering Ca^2+^ in intact cells, exhibited its activity in digitonin-permeabilized cells only at low Ca^2+^ concentrations while it appeared to be inactive at high Ca^2+^ concentrations. These data suggest that the two residues of IML2 are crucial for two distinct Ca^2+^ sensitivities of UCP3 in its contribution to mitochondrial Ca^2+^ uptake. It appears that UCP3 works as a sophisticated molecular switch that is conducive to mitochondrial Ca^2+^ uptake in a high and low Ca^2+^ sensitive manner and allows the protein to meet the demands for mitochondrial Ca^2+^ uptake from different sources ([Fig. 7](#fig0035){ref-type="fig"}).

In order to explain our findings with the two UCP3 mutants, one might speculate that the individual domains independently account for distinct Ca^2+^ sensitivities of the UCP3, thus, a mutation of one domain exclusively affects only the respective Ca^2+^ sensitivity. Accordingly, the mutation in the 171/172 amino acids results in a mutant with remaining high Ca^2+^ sensitivity for achieving uptake of entering Ca^2+^, while the contribution of this UCP3 mutant to mitochondrial uptake under high Ca^2+^ conditions (i.e. intracellular Ca^2+^ release) is prevented. On the other hand, a mutation at position 167 of UCP3 yields a mutant that appears to lack the high Ca^2+^ sensitivity while it achieves mitochondrial Ca^2+^ uptake under high Ca^2+^ conditions.

In agreement with our present findings that the UCP2/3-dependent mitochondrial Ca^2+^ uptake exhibits two Ca^2+^ sensitivities, the modulation of the activity of the mitochondrial Ca^2+^ uniport may be a putative signature of an altered Ca^2+^ sensitivity. Possibly this is accomplished by kinases such as the serine/threonine kinases p38 MAPK [@bib0065; @bib0295; @bib0300], a novel PKC isoform [@bib0065] or a ER or ER-related protein located in mitochondria [@bib0305]. Although it is too speculative to consider a context between these reports and the present findings at the present stage, the report on the existence of respective phosphorylation sites in UCP1 [@bib0310] and the existence of a threonine in the IML2 of UCP2 (position 165) and UCP3 (position 168) ([Fig. 2](#fig0010){ref-type="fig"}) but no other human (and *Drosophila*) UCP family members ([Table 2](#tbl0010){ref-type="table"}) allow to predict such link and animates for further investigation.

Another very interesting possibility on the underlying mechanisms of these two distinct sites that predict the Ca^2+^ sensitivity of the mitochondrial Ca^2+^ uniport, comes with the discovery that the MICU1-encoded mitochondrial EF hand protein is required for the Ca^2+^ uptake in this organelle in HeLa cells [@bib0115]. Unlike UCP2/3, MICU1 is not predicted to form a channel-like structure but rather to serve as a mitochondrial Ca^2+^ sensor as member of a set of proteins that establishes (one particular type of) mitochondrial Ca^2+^ uptake [@bib0115]. While an interaction between UCP2/3 and MICU1 has not been studied so far, one can speculate that the mutations of the two distinct sites of IML2 of UCP2/3 might affect the protein interactions with the Ca^2+^ sensor MICU1, resulting in an altered Ca^2+^ sensitivity of the Ca^2+^ uptake complex.

5. Conclusion {#sec0090}
=============

This work provides further mechanistic information on the contribution of UCP2/3 to mitochondrial Ca^2+^ sequestration. In particular two distinct sites in the IML2 of these proteins have been identified as to be responsible for two distinct Ca^2+^ sensitivities of the UCP2/3-consisting mitochondrial uptake machinery of either intracellularly released or entering Ca^2+^. These findings add to recent reports on the versatility of Ca^2+^ signals that are decoded by the mitochondrial Ca^2+^ uptake machinery and are in agreement with reports on different Ca^2+^ sensitivities of the mitochondrial Ca^2+^ uniporter. The identification of these two molecular sites for Ca^2+^ sensitivity of the contribution of UCP2/3 to mitochondrial Ca^2+^ uptake represents a crucial step in the understanding of the molecular mechanisms of UCP2/3-dependent Ca^2+^ uptake in mitochondria.
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![Chimeras of UCP2/UCP3 with the intermembrane loop 2 of UCP1 revealed efficiency in regard to entering Ca^2+^ but not intracellularly released Ca^2+^. *Panel A*: Schematic illustration of the design of the chimera between UCP2 and UCP3 with UCP1. UCP1 was previously shown to exhibit no effect on mitochondrial Ca^2+^ upon overexpression [@bib0120]. *Panel B*: The intermembrane loops 2 of UCP2 and UCP3 were substituted by that of UCP1 to construct the UCP2^UCP1^ and UCP3^UCP1^ chimeras. Hence, the intermembrane loop 2 of UCP1 was replaced by that from UCP2 (UCP1^UCP2^). *Panel C*: Maximal intracellular Ca^2+^ release from the ER was achieved by the stimulation of 100 μM histamine and 15 μM BHQ in the nominal absence of extracellular Ca^2+^. Strong SOCE activity was achieved by the subsequent readdition of 2 mM extracellular Ca^2+^ in the presence of BHQ in order to prevent ER refilling. To avoid Ca^2+^ uptake via the NCX~mito~ the readdition of Ca^2+^ was performed in the presence of 20 μM CGP 37157. Mitochondrial Ca^2+^ accumulation measured by ratiometric pericam-mt in cells transiently expressing nuclear-targeted GFP alone (Control: *Panel A*, *n* = 33; *Panel B*, *n* = 45) or together with the UCP3^UCP1^ (*Panel A*, *n* = 31) or UCP2^UCP1^ (*Panel B*, *n* = 45) chimera. *Panel D*: Mitochondrial Ca^2+^ signaling visualized with ratiometric pericam-mt in cells transiently expressing nuclear-targeted GFP alone (Control: *n* = 33) or together with wild-type UCP2 (*n* = 26) and UCP3 (*n* = 30). *Panel E*: Mitochondrial Ca^2+^ accumulation was measured with ratiometric pericam-mt in cells transiently expressing nuclear-targeted GFP alone (Control: *n* = 10) or together with the UCP1^UCP2^ chimera (UCP1^UCP2^: *n* = 12). \*^,\#^*P* \< 0.05 vs. control.](gr1){#fig0005}

###### 

Expression of the novel UCP3 mutants UCP3^RE171/172GG^ and UCP3^R167G^ did not affect ER Ca^2+^ signaling and the morphology of the organelles. *Panel A*: Diagram of the design of the UCP3 mutants. By site-directed mutagenesis of amino acid(s) at positions 171 and 172 (UCP3^RE171/172GG^) or 167 (UCP3^R167G^) in the intermembrane loop 2 were/was replaced by [l]{.smallcaps}-glycine. *Panel B*: Expression of UCP3^RE171/172GG^ and UCP3^R167G^ did not affect basal ER Ca^2+^ content. Columns represent the average basal ratio *F*~535~/*F*~480~ of the FRET-based ER Ca^2+^ sensor D1~ER~, which reflects the basal ER Ca^2+^ concentration in control cells (white column, *n* = 26), cells expressing wild-type UCP3 (grey column, *n* = 22), UCP3^RE171/172GG^ (green column, *n* = 25), and UCP3^R167G^ (red column, *n* = 29). Cells were transfected with the plasmid coding for D1~ER~ alone (Control) or cotransfected with the respective constructs coding either for wild-type UCP3, UCP3^RE171/172GG^ or for UCP3^R167G^ in a ratio of 1:3, respectively. *Panel C*: Expression of UCP3^RE171/172GG^ and UCP3^R167G^ did not affect ER Ca^2+^ depletion and refilling. Dynamic changes of the ER Ca^2+^ concentration measured in D1~ER~ expressing control cells (black curve with black circles, *n* = 23), cells co-expressing wild type UCP3 (grey curve with grey circles, *n* = 22), UCP3^RE171/172GG^ (green curve with green circles, *n* = 22), and UCP3^R167G^ (red curve with red circles, *n* = 29) are shown as changes in the ratio(*F*~535~/*F*~480~)/*R*~0~ in response to cell stimulation with 100 μM histamine and 15 μM BHQ in the absence of extracellular Ca^2+^ (1 mM EGTA). ER Ca^2+^ replenishment was induced upon the addition of 2 mM Ca^2+^ after the washout of BHQ. *Panel D*: Expression of UCP3^RE171/172GG^ and UCP3^R167G^ did not affect the overall morphology of the ER. Representative 3-D rendered images showing the overall structure of the ER in control cells (left image), cells expressing UCP3^RE171/172GG^ (middle image) and the UCP3^R167G^ mutant (right image). 3-D rendering was performed using the Imaris 4.0.3 software from Bitplane (Switzerland) from *z*-stacks of single cells expressing D1~ER~ alone or together with the respective UCP3 mutants. *Panel E*: Expression of UCP3^RE171/172GG^ and UCP3^R167G^ did not affect the overall morphology of mitochondria. Representative 3-D rendered images showing the overall structure of mitochondria within control cells (left image), cells expressing UCP3^RE171/172GG^ (middle image) and the UCP3^R167G^ mutant (right image). *Panel F*: The impact of an expression of the UCP3 mutants on the overall appearance of mitochondria was evaluated by calculating the shape factor (SF) that is defined as: SF = 4*πA*/*P*^2^ (where *P* is the perimeter and *A* the area of an object), of mitochondrial structures. Mitochondria were visualized in cells expressing mtDsRed at the *z*-planes with the obvious largest spreading of mitochondria. A SF near 0 indicates a flattened and a SF of 1.0 indicates a perfect spherical mitochondrion. The columns represent the average SF of all mitochondria in control cells expressing mtDsRed alone (white column, *n* = 11), in cells expressing mtDsRed together with UCP3^RE171/172GG^ (green column, *n* = 14), and the UCP3^R167G^ mutant (red column, *n* = 13). SF calculation was performed using the Metamorph^®^ software from Visitron Systems (Puchheim, Germany). *Panel G*: The 3-D rendering of respective *z*-stacks of images of cells expressing mtDsRed, as shown in *Panel E*, allowed an evaluation of the area (left panel), the volume (middle panel) and the number (right panel) of mitochondria per cell. Control cells had an average area of 644.3 ± 39.5 μm^2^ (white column in the left panel, *n* = 31), cells expressing UCP3^RE171/172GG^ revealed an average area of 603.3 ± 40.0 μm^2^ (green column in the left panel, *n* = 16), and cells expressing the UCP3^R167G^ mutant showed an average area of 645.4 ± 60.0 μm^2^ (red column in the left panel, *n* = 19). The average volume of control cells was 84.3 ± 5.8 μm^3^ (white column of the middle panel, *n* = 31), which was not significantly different from the volume of mitochondria in cells expressing UCP3^RE171/172GG^ (average volume was 84.2 ± 7.2 μm^3^, green column of the middle panel, *n* = 16), and UCP3^R167G^ (average volume was 88.3 ± 6.8 μm^3^, red column of the middle panel, *n* = 19). In line with these findings an expression of neither UCP3^RE171/172GG^ nor UCP3^R167G^ affected the overall number of single mitochondria per cell which was 84.1 ± 6.9 in control cells (white column of the right panel, *n* = 31), 73.3 ± 8.9 in cells expressing UCP3^RE171/172GG^ (green column of the right panel *n* = 19), and 76.5 ± 7.4 for cells expressing the UCP3^R167G^ mutant (red column of the right panel, *n* = 19). *Panel H*: The subcellular distribution of mitochondria is presented by plotting the *X* and *Y* coordinates of the center of mass of single mitochondria of individual endothelial cells under control conditions (left panel, black lines with white circles, *n* = 553 mitochondria from 11 cells) in cells expressing the UCP3^RE171/172GG^ mutant (middle panel, green lines with white circles, *n* = 1091 mitochondria from 14 cells) and cells expressing the UCP3^R167G^ mutant (right panel, red lines with white circles, *n* = 709 from 13 cells). The *X* and *Y* coordinates of the centroid of the cells were both set to 0. All data were extracted from respective images of fluo4/AM loaded cells expressing mtDsRed alone (Control) or together with the UCP3 mutants, either UCP3^RE171/172GG^ or UCP3^R167G^, respectively, at those *z*-positions with the maximal dispersal of mitochondria within respective cells. *Panel I*: Histogram of the data presented in *Panel C*. For the histogram the distances of the centroids of single mitochondria from the centroids of the respective cells were used as data sources. The statistical histogram analysis was performed with SigmaPlot^®^ for Windows Version 11.0 (Systat Software Inc., San Jose, CA, USA). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)
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![Site-directed mutagenesis specifically directed the activity of UCP3 towards mitochondrial uptake of either exclusively intracellularly released or entering Ca^2+^ via the SOCE pathway. Maximal intracellular Ca^2+^ mobilization was induced with 100 μM histamine and 15 μM BHQ in the nominal Ca^2+^-free solution. SOCE activity was initiated by the subsequent readdition of 2 mM extracellular Ca^2+^ in the presence of BHQ. *Panels A and B*: Cytosolic Ca^2+^ signals in cells transiently expressing nuclear-targeted GFP alone (Control: *Panel A*, *n* = 13; *Panel B*, *n* = 17), UCP3^RE171/172GG^ (*Panel A*, *n* = 17) or UCP3^R167G^ (*Panel B*, *n* = 20) all together with nuclear-targeted GFP. *Panels C and D*: Mitochondrial Ca^2+^ uptake visualized by ratiometric pericam-mt in endothelial cells transiently expressing nuclear-targeted GFP alone (Control: *Panel C*, *n* = 29; *Panel D*, *n* = 29), wild-type UCP3 (*Panel C*, *n* = 29; *Panel D*, *n* = 29), UCP3^RE171/172GG^ (*Panel C*, *n* = 28) or UCP3^R167G^ (*Panel D*, *n* = 25) all together with nuclear-targeted GFP. Ca^2+^ addition to pre-stimulated cells was performed in the presence of 20 μM CGP 37157 to avoid mitochondrial Ca^2+^ loading via the reversed mode of the NCX~mito~. \**P* \< 0.05 vs. control.](gr3){#fig0015}

![Mitochondrial Ca^2+^ uptake in cells expressing the UCP3 mutants UCP3^RE171/172GG^ or UCP3^R167G^ was highly sensitive to a depolarization of mitochondria with FCCP and oligomycin. Strong ER Ca^2+^ release was achieved by cell stimulation with 100 μM histamine and 15 μM BHQ in the absence of extracellular Ca^2+^. The subsequent addition of 2 mM Ca^2+^ to prestimulated cells was used to measure mitochondrial Ca^2+^ sequestration upon SOCE. Prior to cell stimulation the IMM was depolarized using 2 μM FCCP in the presence of 2 μM oligomycine and 10 μM CGP 37157. The mixture of FCCP, oligomycin and CGP 37157 was added 3 min prior to cell stimulation with histamine/BHQ. *Panel A*: Representative mitochondrial Ca^2+^ signals under conditions of IMM depolarization that were evoked by intracellular Ca^2+^ mobilization from the ER in control cells (black curve) cells expressing wild-type UCP3 (grey curve), UCP3^RE171/172GG^ (green curve), and the UCP3^R167G^ mutant (red curve), respectively. *Panel B*: Columns represent the average of the maximal peaks of mitochondrial Ca^2+^ signals that were measured in cells expressing ratiometric pericam-mt with and without IMM depolarization under control conditions (plain white column, without IMM depolarization, *n* = 15 and checkered white column, plus FCCP, oligomycin and CGP 37157, *n* = 14), in cells expressing wild type UCP3 (plain grey column, without IMM depolarization, *n* = 12 and checkered grey column, plus FCCP, oligomycin and CGP 37157, *n* = 17), in cells expressing the UCP3^RE171/172GG^ mutant (plain green column, without IMM depolarization, *n* = 14 and checkered green column, plus FCCP, oligomycin and CGP 37157, *n* = 15), and in cells expressing UCP3^R167G^ (plain red column, without IMM depolarization, *n* = 14 and checkered red column, plus FCCP, oligomycin and CGP 37157, *n* = 15). *Panel C*: Representative mitochondrial Ca^2+^ signals under conditions of IMM depolarization that were evoked by SOCE in control cells (black curve) cells expressing wild-type UCP3 (grey curve), UCP3^RE171/172GG^ (green curve), and the UCP3^R167G^ mutant (red curve). *Panel D*: Statistical data regarding the maximal peaks of mitochondrial Ca^2+^ signals that were fueled by SOCE with and without IMM depolarization under control conditions (plain white column, without IMM depolarization, *n* = 29 and checkered white column, plus FCCP, oligomycin and CGP 37157, *n* = 15), in cells expressing wild type UCP3 (plain grey column, without IMM depolarization, *n* = 30 and checkered grey column, plus FCCP, oligomycin and CGP 37157, *n* = 12), in cells expressing the UCP3^RE171/172GG^ mutant (plain green column, without IMM depolarization, *n* = 28 and checkered green column, plus FCCP, oligomycin and CGP 37157, *n* = 14), and in cells expressing UCP3^R167G^ (plain red column, without IMM depolarization, *n* = 25 and checkered red column, plus FCCP, oligomycin and CGP 37157, *n* = 14). \**P* \< 0.05 vs. control in the absence of FCCP/oligomycin/CGP 37157 and ^\#^*P* \< 0.05 vs. control in the presence of FCCP/oligomycin/CGP 37157. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)](gr4){#fig0020}

![Mitochondrial Ca^2+^ sequestration of intracellularly released Ca^2+^ and entering Ca^2+^ was different in terms of its promptitude and reflected morphological differences between contact sites of mitochondria with the ER and the plasma membrane. *Panel A*: Correlation between the time-to-reach-maximum-rate ($T_{R_{\text{max}}}$) and maximal rate of Ca^2+^ sequestration (*R*~max~ (1 − *F*~430~/*F*~0~)/d*t*) of mitochondrial Ca^2+^ accumulation upon Ca^2+^ supply with varying intensities from different sources (i.e. intracellular Ca^2+^ release vs. entering Ca^2+^). *Panel B*: *Left panel*: Comparison between the contact sites of the mitochondria in regard to the ER (*n* = 22 [@bib0120]) and the plasma membrane (*n* = 11). *Middle panel*: 3-D reconstructions of representative cell sections indicating mitochondria-ER contact sites (upper image) and distances between mitochondria and the plasma membrane (lower image). *Right panel*: Analysis of the total surface area of the ER (*n* = 26) and the plasma membrane (*n* = 8).](gr5){#fig0025}

![The UCP3 mutants UCP3^RE171/172GG^ and UCP3^R167G^ exhibited different Ca^2+^ sensitivities in digitonin-permeabilized cells and all mitochondrial Ca^2+^ signals were sensitive to Ru360. Cells expressing ratiometric pericam-mt were treated for 3 min with 3 μM digitonin for mild plasma membrane permeabilization without affecting mitochondria. Subsequently mitochondrial Ca^2+^ accumulation was measured upon the addition of different Ca^2+^ concentrations. In all experiments where Ru360 was used, cells were incubated with 10 μM Ru360 over night prior to Ca^2+^ measurements. *Panel A*: Representative tracings of mitochondrial Ca^2+^ accumulation in percentage of the respective control signals (Δ~max~ 1 − *F*~430~/*F*~0~ was defined as 100%) upon the addition of either a low Ca^2+^ concentration (*left panel*), which corresponded to an actual Ca^2+^ concentration of 174 ± 18 nM (*n* = 17, see Section [2](#sec0010){ref-type="sec"}), middle Ca^2+^ concentration (*middle panel*), which corresponded to an actual Ca^2+^ concentration of 319 ± 21 nM (*n* = 20, see Section [2](#sec0010){ref-type="sec"}) or a high Ca^2+^ concentration (*right panel*), which corresponded to an actual Ca^2+^ concentration of 921 ± 119 nM (*n* = 17, see Section [2](#sec0010){ref-type="sec"}) in mild digitonin-permeabilized control cells (black curves), cells expressing wild-type UCP3 (grey curves), UCP3^RE171/172GG^ (green curves), or the UCP3^R167G^ mutant (red curves). *Panel B*: Statistical data concerning the curves presented in *Panel A*. Columns represent the average Δ~max~ 1 − *F*~430~/*F*~0~ values of mitochondrial Ca^2+^ signals upon the addition of the low Ca^2+^ concentration (Control cells, left white column, *n* = 8; cells overexpressing wild-type UCP3, left grey column, *n* = 8; cells expressing UCP3^RE171/172GG^, left green column, *n* = 7; and cell expressing the UCP3^R167G^ mutant, left red column, *n* = 9), the middle Ca^2+^ concentration (Control cells, middle white column, *n* = 10; cells overexpressing wild-type UCP3, middle grey column, *n* = 10; cells expressing UCP3^RE171/172GG^, middle green column, *n* = 9; and cell expressing the UCP3^R167G^ mutant, middle red column, *n* = 8), and the high Ca^2+^ concentration (Control cells, right white column, *n* = 24; cells overexpressing wild-type UCP3, right grey column, *n* = 26; cells expressing UCP3^RE171/172GG^, right green column, *n* = 23; and cell expressing the UCP3^R167G^ mutant, right red column, *n* = 27). \*^,^*P* \< *0.05* vs. the respective control and ^\#^*P* \< *0.05* between cells expressing UCP3^RE171/172GG^ and UCP3^R167G^. *Panel C*: Representative curves of mitochondrial Ca^2+^ accumulation in digitonin-permeabilized cells upon the addition of a middle Ca^2+^ concentration, which corresponded to an actual Ca^2+^ concentration of 319 ± 21 nM (*n* = 20, see Section [2](#sec0010){ref-type="sec"}), in the absence and presence of 1 μM Ru360 in control cells (black curves), cells overexpressing the wild-type UCP3 (grey curves), cells expressing UCP3^RE171/172GG^ (green curves), and cells expressing the UCP3^R167G^ mutant (red curves). *Panel D*: Statistics to the mitochondrial Ca^2+^ accumulation in the absence and presence of Ru360 as presented in panel C. The average Δ~max~ 1 − *F*~430~/*F*~0~ values of the mitochondrial Ca^2+^ signals are presented for control cells without Ru360 (plain white column, *n* = 14) and in the presence of 1 μM Ru360 (checkered white column, *n* = 15), cells overexpressing wild-type UCP3 in the absence (plain grey column, *n* = 16) and presence of Ru360 (checkered grey column, *n* = 14), cells expressing UCP3^RE171/172GG^ without (plain green column, *n* = 15) and with Ru360 (checkered green column, *n* = 15), and in cells expressing the UCP3^R167G^ mutant without (plain red column, *n* = 15) and with Ru360 (checkered red column, *n* = 13). \**P* \< 0.05 vs. control in the absence of Ru360 and ^\#^*P* \< 0.05 vs. the respective signal in the absence of Ru360. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)](gr6){#fig0030}

![UCP3 might contribute to a complex molecular switch that adjusts the mitochondrial Ca^2+^ uptake machinery to high and low Ca^2+^ signals. Schematic illustration of a putative UCP3 containing mitochondrial Ca^2+^ uniport machinery with interrelated Ca^2+^ sensitivities. *Upper panels*: A high Ca^2+^ concentration at the UCP3 dependent mitochondrial Ca^2+^ uptake machinery uncloses a certain distinct transition for Ca^2+^ ions through the IMM, while closuring a path for the mitochondrial uptake of low Ca^2+^ signals. *Lower panels*: Low Ca^2+^ signals are sequestered via another way through the UCP3 dependent mitochondrial Ca^2+^ uniport machinery, while under these conditions the path for mitochondrial Ca^2+^ uptake of high Ca^2+^ signals remains locked due to a low Ca^2+^ sensitivity.](gr7){#fig0035}

###### 

Overview on the effect of various UCPs, and their chimeras and mutants on mitochondrial Ca^2+^ uptake in endothelial cells.

  Protein                    Effect on mitochondrial Ca^2+^ uptake in response to   
  -------------------------- ------------------------------------------------------ -----
  Constitutive UCP2^a^       \+                                                     o
  Constitutive UCP3^a^       \+                                                     o
  Overexpressed UCP2^b^      ++                                                     +++
  Overexpressed UCP3^b^      ++                                                     +++
  Overexpressed UCP1^b^      o                                                      o
  UCP2^6G^ mutant^b^         \-                                                     \--
  UCP3^6G^ mutant^b^         o                                                      \--
  UCP2^UCP1^ chimera         o                                                      +++
  UCP3^UCP1^ chimera         o                                                      +++
  UCP1^UCP2^ chimera         o                                                      o
  UCP3^RE171/172GG^ mutant   o                                                      +++
  UCP3^R167G^ mutant         ++                                                     o

+, involved in mitochondrial Ca^2+^ uptake.

++, strongly elevated mitochondrial accumulation of *entering Ca*^*2+*^ upon overexpression.

+++, greatly elevated mitochondrial uptake of *intracellularly released Ca*^*2+*^ upon overexpression.

o, no effect on mitochondrial Ca^2+^ uptake upon overexpression.

-, slightly inhibiting mitochondrial Ca^2+^ accumulation.

\--, greatly inhibiting effect on mitochondrial Ca^2+^ uptake.

^a^For further information please see Waldeck-Weiermair et al. [@bib0165].

^b^These data were part of previous work [@bib0120].

###### 

Comparison of the amino acid sequence of the intermembrane loop 2 in various UCPs of different species.

  Protein             Position in protein   Sequence
  ------------------- --------------------- --------------------------
  *Human* UCP2        159--170              T V N A Y K T I A R E E
  *Human* UCP3        162--173              T M D A Y R T I A R E E
  *Human* UCP4        173--184              V H H A F A K I L A E G
  *Human* UCP5        180--191              M I G S F I D I Q Q E G
  *Drosophila* UCP4   191--201              G -- H A F R Q I V Q R G
  *Drosophila* UCP5   151--162              L L G C F G E I Y K Y E
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